MetLife Investment Management’s Vectren Corporation VVC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-50,660
Closed -$3.65M 2630
2018
Q4
$3.65M Sell
50,660
-205
-0.4% -$14.7K 0.04% 416
2018
Q3
$3.64M Sell
50,865
-1,351
-3% -$96.4K 0.04% 550
2018
Q2
$3.73M Buy
52,216
+395
+0.8% +$27.3K 0.04% 464
2018
Q1
$3.31M Sell
51,821
-695
-1% -$43K 0.04% 549
2017
Q4
$3.42M Buy
+52,516
New +$3.53M 0.04% 560

Other funds holding VVC

MetLife Investment Management's VVC Position: Q1 2019 in Review

MetLife Investment Management sold out of Vectren Corporation (VVC) in Q1 2019, closing a stake of 50,660 shares — an estimated $3.65M sold.

MetLife Investment Management first reported a position in VVC in Q4 2017 and held it in 5 quarters. The position peaked at $3.73M in Q2 2018. 1 fund tracked by Wall St. Rank holds VVC as of Q1 2019.

  • MetLife Investment Management reported no remaining Vectren Corporation position as of Q1 2019 after selling out during the quarter.
  • MetLife Investment Management sold 50,660 Vectren Corporation shares in Q1 2019, an estimated $3.65M.
  • MetLife Investment Management first reported a position in Vectren Corporation in Q4 2017 and held it in 5 quarters.
  • MetLife Investment Management's Vectren Corporation position peaked at $3.73M in Q2 2018.
  • 1 fund tracked by Wall St. Rank held Vectren Corporation as of Q1 2019.

Based on MetLife Investment Management's 13F filing for Q1 2019, filed 15 May 2019.